Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients

    NEXT STORY
    Spring Bank Submits IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
    PREV STORY
    EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp

    author_avatar
    NASDAQ Market News

    Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China

    author_avatar
    NASDAQ Market News

    Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)

    author_avatar
    NASDAQ Market News